Congratulations to Prof. Fabrice André, member of our Scientific Board, on his appointment as the research director of the Gustave Roussy Institute in Villejuif.
More information in the press release (in French)
Congratulations to the teams of Prof. George Coukos and Prof. Melita Irving, both working at CHUV/UNIL. In collaboration with EPFL scientists, they have developed a system to counter certain toxic side effects of immunotherapies, thus providing new hope for the treatment of solid tumors. Their research is supported by the ISREC Foundation.
Congratulations to Prof. Douglas Hanahan who is being appointed Distinguished Scholar of Ludwig. A pioneering molecular biologist and renowned cancer researcher, Douglas Hanahan is director of ISREC@epfl since 2009.
World Cancer Day takes place every year on February 4 to unite the world in the fight against cancer. This day aims to raise awareness by spreading information concerning the disease.
Congratulations to Efe Erdes for his publication in the “Journal for ImmunoTherapy of Cancer”. His article describes the chronic TCR-MHC interactions that limit the functional potential of TCR affinity-increased CD8 T lymphocytes. His research, performed in the lab of Dr. Nathalie Rufer (Oncology Department, UNIL/CHUV), was supported by the ISREC foundation.
Congratulations to Prof David Gfeller (UNIL/SIB), Dr. Michal Bassani-Sternberg (CHUV/UNIL) and Julien Racle (UNIL/SIB): the results of their work provide new perspectives for both immunotherapy and basic research regarding the interaction between cancer and the immune system. These investigations are supported by the ISREC Foundation.
More information (in French)
and in the journal Nature Biotechnology
Congratulations are in order for the research teams of Prof. Douglas Hanahan, director of the ISREC@epfl. Their work has led to the identification of a signaling pathway used by mammary tumors to form metastases in the brain. This discovery has been published in the prestigious journal Nature.
Once again, the SUR-SRP “Summer Research” program (July 8 to August 29), organized by the UNIL and the EPFL and supported by the ISREC Foundation, was a huge success. The students returned home with many new impressions and ideas, grateful for this exciting opportunity.
The Swiss Institute for Experimental Cancer Research was established 55 years ago in Lausanne. A dream formulated in those days has now come true: the AGORA – Pôle de recherche sur le cancer is a platform that brings research to the patient’s bedside.
See our Annual Report 2018!